BioSpace News Archive

Pharm Country

American Medical Association Officially Recognizes COMLEX-USA’s Equality with USMLE

On Tuesday, November 13, 2018, the American Medical Association’s (AMA) House of Delegates voted unanimously to approve Resolution 955 “Equality for COMLEX and USMLE.”

December 3, 2018
·
3 min read
Kyowa Kirin Presents Additional Analyses of MAVORIC Trial

Kyowa Hakko Kirin Co., Ltd., (Kyowa Kirin) announces that additional data from the MAVORIC trial (Mogamulizumab anti-CCR4 Antibody Versus ComparatOR In CTCL) will be presented at the 60th Annual Meeting of the American Society of Hematology (ASH), held in San Diego, California, on December 1-4.

December 3, 2018
·
7 min read
Business

Chuck Sowers Joins Blue Cross Blue Shield of Arizona As General Manager Of Government Business

Blue Cross Blue Shield of Arizona (BCBSAZ) has named Chuck Sowers as its general manager of government business.

December 3, 2018
·
1 min read
Drug Development

Genentech’s Hemlibra (emicizumab-kxwh) Provided Sustained Bleed Control in the Largest Pivotal Study to Date of Children With Hemophilia A With Factor VIII Inhibitors

Nearly 77 percent of children receiving Hemlibra once weekly experienced zero treated bleeds

December 3, 2018
·
12 min read
Drug Development

BIVV001 Phase 1/2a Data Presented at ASH Underscore Potential for Once Weekly Dosing with Sustained High Factor Levels in Hemophilia A

Early data (n=2) show an unprecedented half-life of 44 hours with a single 65 IU/kg dose of BIVV001, significantly longer than the half-life observed with a short-acting recombinant factor VIII therapy

December 3, 2018
·
5 min read
Business

WorkSafe Sask., University of Fredericton partner to support workplace psychological health

The Saskatchewan Workers’ Compensation Board (WCB) and the University of Fredericton (UFred) have signed a partnership agreement to increase access to training and resources for Saskatchewan employers to create psychologically healthy workplaces.

December 3, 2018
·
4 min read
Drug Development

IMBRUVICA® (ibrutinib) Phase 3 Combination Data with Obinutuzumab Finds Significant Improvement in Progression-Free Survival (PFS) Over Standard Chemoimmunotherapy of Chlorambucil Plus Obinutuzumab

These data were included in the recent sNDA accepted by the U.S. FDA, which received Priority Review, and could lead to the first chemotherapy-free anti-CD20 combination approved for first-line CLL treatment

December 3, 2018
·
16 min read
Business

Children’s Institute Names Dr. Todd Sosna As Chief Program Officer

Children’s Institute announced Todd Sosna, Ph.D. will become their Chief Program Officer effective December 3, 2018.

December 3, 2018
·
2 min read
Pharm Country

National Gathering of the Rare Disease Community and Health Professionals Launched with 2019 Living Rare, Living Stronger | NORD Patient & Family Forum

Featuring the Rare Impact Awards

December 3, 2018
·
2 min read
Pharm Country

Atlantic Health System’s Morristown Medical Center Performs World’s First Catheter-Based Mitral Valve Repair in CLASP IID Pivotal Trial

CLASP IID Trial Will Evaluate Edwards PASCAL Transcatheter Mitral Valve Repair System

December 3, 2018
·
5 min read